Stefan Dubel PhD

Dr. Stefan Dubel is Full Professor of Biotechnology and Director of the respective department at the Braunschweig University of Technology, Germany. After obtaining his Ph.D. from the University of Heidelberg, in 1989 he joined the German Cancer Research Center (DKFZ) where he co-pioneered in vitro antibody selection technologies, resulting in several key inventions including antibody phage display and human antibody libraries with randomised CDRs. His lab continued to contribute to multiple topics related to human antibody engineering and phage display, e.g. Hyperphage technology (2001), single chain Fab fragments (2006) and targeted human RNases for cancer therapy (2008).

Further contributions were made to the fields of human IgG production, infectious disease research, novel recombinant production systems (e.g. in Bacillus megaterium), high throughput antibody generation, intrabodies and nanobiotechnology. Prof. Dübel serves on boards of scientific journals and as a consultant to biotech and pharma companies. Further, he is initiator of the “Antibody Factory” of the German National Genome Research Network and editor of the three volume “Handbook of Therapeutic Antibodies” and other antibody engineering books.